Literature DB >> 3195256

Occurrence and clinical importance of the pathogenic serogroup O: 5, 27 of Yersinia enterocolitica in the Federal Republic of Germany and methods for its serological and bacteriological identification.

S Aleksić1, J Bockemühl, H H Wuthe, V Aleksić.   

Abstract

Despite its world-wide distribution, the pathogenic serogroup O: 5, 27 of Yersinia enterocolitica (Y. e.) has scarcely been considered in the Federal Republic of Germany. In the 1980 to 1986 period, a total of 74 strains from patients was identified at the National Reference Centre for Salmonella, Hamburg. The clinical manifestations of the cases was not different from those associated with Y. e. O: 3 and O: 9 infections. Six out of 8 patients from whom serum samples were available, developed moderate agglutination titres (1:80-1:1280). Only 8 of the 74 strains were negative in in vitro virulence tests. A list of biochemical tests is given which permit a differentiation of the pathogenic serogroup O: 5, 27 from the apathogenic Y. e. O: 5 which is widely distributed in the environment. Serological studies revealed different H antigens in both serogroups. The O antigen factor 27, and a subfactor O: 5(2) which is typical of Y. e. serogroup O: 5, are further differential markers; the production of both factor sera is described. Besides serogroups O: 3 and O: 9, Y. e. O: 5, 27 must be considered as an aetiological agent of human yersiniosis in the Federal Republic of Germany.

Entities:  

Mesh:

Year:  1988        PMID: 3195256     DOI: 10.1016/s0176-6724(88)80096-8

Source DB:  PubMed          Journal:  Zentralbl Bakteriol Mikrobiol Hyg A        ISSN: 0176-6724


  2 in total

1.  Seroprevalence of anti-Yersinia antibodies in healthy Austrians.

Authors:  H Tomaso; G Mooseder; S Al Dahouk; C Bartling; H C Scholz; R Strauss; T M Treu; H Neubauer
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

2.  Differentiation of Yersinia enterocolitica serotype O:5,27 strains by phenotypic and molecular techniques.

Authors:  H Fukushima; M Gomyoda; S Aleksic; M Tsubokura
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.